Q1 Earnings Estimate for Ovid Therapeutics Issued By Wedbush
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Investment analysts at Wedbush boosted their Q1 2025 earnings estimates for shares of Ovid Therapeutics in a report issued on Wednesday, March 12th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.13) per share for the quarter, up from their prior estimate of ($0.15). […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Investment analysts at Wedbush boosted their Q1 2025 earnings estimates for shares of Ovid Therapeutics in a report issued on Wednesday, March 12th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.13) per share for the quarter, up from their prior estimate of ($0.15). […]
